Tower Research Capital LLC (TRC) - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 19 filers reported holding EYEGATE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$31,000
+1450.0%
13,832
+2836.7%
0.00%
Q4 2020$2,000
-66.7%
471
-67.3%
0.00%
Q3 2020$6,0001,4420.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,815,500$8,950,0000.30%
Sterling Financial Planning, Inc. 1,171$6,0000.01%
UBS Group AG 3,991$20,0000.00%
OSAIC HOLDINGS, INC. 468$2,0000.00%
US BANCORP \DE\ 2,710$13,0000.00%
WELLS FARGO & COMPANY/MN 34$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 12,656$62,0000.00%
North Star Investment Management Corp. 20$00.00%
MORGAN STANLEY 466$2,0000.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders